ATS Dermagraft Approval Breaks Apligraf Monopoly In Chronic Wounds

Advanced Tissue Sciences plans a PMA supplement supported by an ongoing 240-patient U.S. trial for expanded use of its Dermagraft tissue-engineered, living dermal substitute to treat venous ulcers. FDA approval for diabetic foot ulcers was received Sept. 28.